Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia

B-cell chronic lymphocytic leukaemia (B-CLL) remains an incurable disease due to the high risk of relapse, even after complete remission, raising the need to control and eliminate residual tumor cells in long term. Adoptive T cell therapy with genetically engineered specificity is thought to fulfil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Koehler, Philipp, Schmidt, Patrick, Hombach, Andreas A., Hallek, Michael, Abken, Hinrich
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2012
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3152962/
https://ncbi.nlm.nih.gov/pubmed/21837241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/595060
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars